Home » Topics » BioWorld Science

BioWorld Science
RSS

ESI Lederle launches generic acyclovir

April 29, 1997

Target of action of AR-177 elucidated

April 29, 1997

MDL-101731 shows potent antiviral activity in vitro

April 29, 1997

Potent antitumor farnesyltransferase inhibitors discovered by Parke-Davis

April 29, 1997

SKB describes potent, selective IL-8beta receptor antagonists

April 29, 1997

Potent and selective iNOS inhibitor disclosed by Merck & Co.

April 29, 1997

DuPont Merck describes potent, orally bioavailable cyclic urea HIV protease inhibitor

April 29, 1997

PD-170262: potent and selective PDGF TK inhibitor from Parke-Davis

April 29, 1997

Pharmacia & Upjohn prepares potent and selective dopamine D4 antagonist

April 29, 1997

Pharmacokinetic data for pentafuside in rodents, monkeys and man

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...